Both angiotensin II and vascular endothelial growth factor are angiogenic a
gents that have recently been implicated in the pathogenesis of proliferati
ve diabetic retinopathy. In this study, retinal neovascularization was exam
ined in a model of retinopathy of prematurity with the use of neonatal tran
sgenic (mRen-2)27 rats, which overexpress renin in tissues, and Sprague-Daw
ley rats. Blockers of the renin-angiotensin system were administered during
the neovascularization period, The ACE inhibitor lisinopril and the angiot
ensin type 1 receptor antagonist losartan both increased retinal renin leve
ls and prevented inner retinal blood vessel growth. Quantitative in situ hy
bridization revealed that the expression of vascular endothelial growth fac
tor and its type 2 receptor in the inner retina and proliferating blood ves
sels were increased in rats with retinopathy of prematurity, Lisinopril red
uced both retinal vascular endothelial growth factor and its type 2 recepto
r mRNA in retinopathy of prematurity rats, whereas losartan had no effect,
It is predicted that agents that interrupt the renin-angiotensin system may
play an important role as retinoprotective agents in various forms of prol
iferative retinopathy.